The girl died a few days after being vaccinated. At the moment no link has been established, but his case has been reported to pharmacovigilance.
He studied at the Gardanne Agricultural Secondary School in the Bouches du Rhône and died when he was just 16 years old.
The girl died on September 21 in Aix-en-Provence, just days after receiving a dose of the Pfizer vaccine.
So inevitably, when such a death occurs after an injection, a possible link to the vaccine is considered and should be studied.
Especially since since June 15, children over 12 years old are not only eligible for the Covid vaccine but also the health pass will be mandatory for them as of this Thursday, September 30.
A pulmonary embolism as a hypothesis
At the moment, no data has been leaked on the exact causes of his death, the circumstances have not been revealed, but according to a source close to the file, the hypothesis of pulmonary embolism would be considered, according to Liberation.
Furthermore, there was no autopsy report to clarify the causes of his death.
Case reported and investigations initiated
However, the case has been reported to pharmacovigilance.
Which is quite logical since, as specified by the National Agency for Drug Safety, “as part of the reinforced surveillance of the vaccines used against Covid-19, a pharmacovigilance survey is established to monitor the profile in real time. the safety of the vaccines available in France based on statements made by health professionals, people who have been vaccinated or people close to them “.
Investigations are underway to establish a possible link between this young woman’s death and the vaccine.
But the investigation has only just begun and the next committee will meet on October 7, the results of the investigations will not be communicated sooner.
Other avenues explored
Beyond the vaccine, other pathways will be explored if we consider the pulmonary embolism hypothesis.
Other factors can cause this type of obstruction by a blood clot such as smoking, taking contraceptives …
No other case reported
In its latest report, the ANSM (the National Agency for Drug Safety) is quite reassuring about the safety of the vaccine for young people aged 12 to 17 years.
“Since June 15, 2021, vaccination in the youngest subjects (12-18 years) is possible with the Comirnaty vaccine (the Pfizer vaccine),” the agency specifies.
Before adding: “As of September 16, 2021, more than 4.5 million of them have received at least one injection. A total of 591 cases, including 206 severe, have been reported after vaccination. No specific signal has been received. . Identified in the youngest subjects. Based on the data analyzed, the safety profile of the Comirnaty vaccine in young people aged 12 to 18 years is broadly comparable to that of adults. “